“Novel Preclinical Platform for Metastatic Retinoblastoma Research: Primary Cell Cultures and Xenograft Models Inform Clinical Decisions and Drug Discovery”

https://pubmed.ncbi.nlm.nih.gov/38117242

This study developed and characterized a novel preclinical platform using primary cell cultures and xenograft models of metastatic retinoblastoma to inform clinical decisions and identify potential drug candidates for this aggressive cancer.